(株)リボミックの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4591/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/03/01 | 日証協 | 354,979株 | +9.94% | 84,000株 | +24.48% | 384,616株 | -1.41% | 49,107株 | -7.71% |
2019/02/22 | 日証協 | 322,879株 | +0.27% | 67,479株 | +133.49% | 390,119株 | +2.96% | 53,208株 | +358.41% |
2019/02/15 | 日証協 | 322,000株 | +0.56% | 28,900株 | -64.45% | 378,911株 | +0.08% | 11,607株 | -41.67% |
2019/02/08 | 日証協 | 320,200株 | -18.3% | 81,300株 | -10.24% | 378,604株 | -14.17% | 19,900株 | -73.48% |
2019/02/01 | 日証協 | 391,900株 | +13.5% | 90,579株 | +7.73% | 441,104株 | +8.04% | 75,045株 | +85.75% |
2019/01/25 | 日証協 | 345,279株 | -5.04% | 84,079株 | +383.21% | 408,289株 | -5.16% | 40,400株 | +1293.1% |
2019/01/18 | 日証協 | 363,600株 | -18.13% | 17,400株 | -67.9% | 430,489株 | -8.58% | 2,900株 | -90.61% |
2019/01/11 | 日証協 | 444,100株 | -28.83% | 54,203株 | -46.33% | 470,898株 | -21.87% | 30,900株 | +1831.25% |
2019/01/04 | 日証協 | 624,000株 | +25.33% | 101,000株 | -15.69% | 602,698株 | +18.85% | 1,600株 | -98.61% |
2018/12/28 | 日証協 | 497,883株 | +4.93% | 119,800株 | +35.98% | 507,098株 | +2.71% | 115,300株 | +188.97% |
2018/12/21 | 日証協 | 474,483株 | -17.59% | 88,100株 | -47.52% | 493,698株 | -14.12% | 39,900株 | -22.4% |
2018/12/14 | 日証協 | 575,783株 | +27.19% | 167,883株 | +51.25% | 574,898株 | +16.47% | 51,415株 | -43.75% |
2018/12/07 | 日証協 | 452,683株 | -5.83% | 111,000株 | -3.67% | 493,583株 | -7.27% | 91,403株 | +24.7% |
2018/11/30 | 日証協 | 480,683株 | +19.34% | 115,232株 | +123.75% | 532,280株 | +13.74% | 73,300株 | +192.03% |
2018/11/22 | 日証協 | 402,783株 | +10.27% | 51,500株 | -32.66% | 467,980株 | +3.61% | 25,100株 | -16.05% |
2018/11/16 | 日証協 | 365,283株 | -10.44% | 76,483株 | -51.15% | 451,680株 | -9.32% | 29,900株 | -70.51% |
2018/11/09 | 日証協 | 407,883株 | +35.28% | 156,566株 | +21.56% | 498,080株 | +18.65% | 101,400株 | +35.92% |
2018/11/02 | 日証協 | 301,500株 | +9.32% | 128,800株 | +607.69% | 419,780株 | 0% | 74,600株 | +230.09% |
2018/10/26 | 日証協 | 275,800株 | -8.83% | 18,200株 | +4450% | 419,780株 | -0.85% | 22,600株 | +39.51% |
※株式分割は考慮していませんのでご注意ください。
Page Top